Novo Nordisk Shares Surge on New Obesity Drug Results Jan 24, 2025 · · wsj.com read more » Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial. Read more »
